The LTC Innovation Blog

In 2026, long-term care pharmacies must evolve to meet the rising demand for medication safety, compliance, and efficiency. With more medications per patient and increasing regulatory scrutiny, a data-driven medication management review process is essential to ensure safe, effective care. Here’s how FrameworkInsight can help pharmacies stay ahead.

As the Maximum Fair Price (MFP) era looms large for long-term care (LTC) pharmacies, the need for preparation has never been greater. The Inflation Reduction Act (IRA), which introduces significant changes to Medicare drug pricing, presents both a challenge and an opportunity for LTC pharmacies. Success in this new environment will depend on pharmacies' ability to adapt strategically while optimizing operations.

Long-term care pharmacies are heading into one of the most significant reimbursement shifts in years. With the first set of medications entering the Medicare Drug Price Negotiation Program on January 1, 2026, LTC pharmacies must prepare now for the operational, financial, and clinical ripple effects that come with the introduction of the Maximum Fair Price (MFP) reimbursement framework.

Compliance is the foundation of safe, effective pharmacy operations in long-term care (LTC) settings. The regulatory landscape is complex, with strict oversight designed to protect patients and ensure proper medication management. Failure to comply can lead to severe consequences—fines, legal action, reputational damage, and (most importantly) harm to residents who rely on accurate and timely medication delivery.

Decoding the Decline in Reimbursements By Mark Fulton, PharmD, MBA, BCNSP, NSC-II